Clinical trial
Interventional Study of Levodopa Replacement on Retinal Function in Oculocutaneous Albinism
NCT01663935 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interventional Study of Levodopa Replacement on Retinal Function in Oculocutaneous Albinism
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- October 17, 2012
- Completion date
- April 12, 2018
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
albinism, oculocutaneous albinism